Follow
Kosheli Thapa Magar
Kosheli Thapa Magar
Verified email at stu.cpu.edu.cn
Title
Cited by
Cited by
Year
Liposome-based delivery of biological drugs
KT Magar, GF Boafo, X Li, Z Chen, W He
Chinese Chemical Letters 33 (2), 587-596, 2022
902022
Approved nanomedicine against diseases
Y Jia, Y Jiang, Y He, W Zhang, J Zou, KT Magar, H Boucetta, C Teng, ...
Pharmaceutics 15 (3), 774, 2023
212023
The role of cryoprotective agents in liposome stabilization and preservation
GF Boafo, KT Magar, MD Ekpo, W Qian, S Tan, C Chen
International journal of molecular sciences 23 (20), 12487, 2022
172022
Metal phenolic network-stabilized nanocrystals of andrographolide to alleviate macrophage-mediated inflammation in-vitro
KT Magar, GF Boafo, M Zoulikha, X Jiang, X Li, Q Xiao, X Xing, X Wang, ...
Chinese Chemical Letters 34 (1), 107453, 2023
162023
Thin layer chromatography (TLC) based chemical profiling and antioxidant activity of selected Nepalese medicinal plants
S Giri, U Giri, K Subedi, KT Magar, S Pant, KR Joshi
Journal of Health and Allied Sciences 10 (2), 15-22, 2020
92020
Multifunctional nanoparticle-mediated combining therapy for human diseases
X Li, X Peng, M Zoulikha, GF Boafo, KT Magar, Y Ju, W He
Signal Transduction and Targeted Therapy 9 (1), 1, 2024
62024
Nanosized-drug delivery systems for treating inflammatory atherosclerosis
KT Magar
International Journal of Pharmaceutical and Clinical Research 3 (1, 2021), 15-18, 2021
2021
Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes
KT Magar
The system can't perform the operation now. Try again later.
Articles 1–8